Abstract

Rapid and reliable detection of disease-associated DNA methylation patterns has major potential to advance molecular diagnostics and underpin research investigations. We describe the development and validation of minimal methylation classifier (MIMIC), combining CpG signature design from genome-wide datasets, multiplex-PCR and detection by single-base extension and MALDI-TOF mass spectrometry, in a novel method to assess multi-locus DNA methylation profiles within routine clinically-applicable assays. We illustrate the application of MIMIC to successfully identify the methylation-dependent diagnostic molecular subgroups of medulloblastoma (the most common malignant childhood brain tumour), using scant/low-quality samples remaining from the most recently completed pan-European medulloblastoma clinical trial, refractory to analysis by conventional genome-wide DNA methylation analysis. Using this approach, we identify critical DNA methylation patterns from previously inaccessible cohorts, and reveal novel survival differences between the medulloblastoma disease subgroups with significant potential for clinical exploitation.

Details

Title
Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures
Author
Schwalbe, E C 1 ; Hicks, D 2 ; Rafiee, G 3 ; Bashton, M 2   VIAFID ORCID Logo  ; Gohlke, H 4 ; Enshaei, A 2 ; Potluri, S 2 ; Matthiesen, J 2 ; Mather, M 2   VIAFID ORCID Logo  ; Taleongpong, P 2 ; Chaston, R 5 ; Silmon, A 5 ; Curtis, A 5 ; Lindsey, J C 2 ; Crosier, S 2 ; Smith, A J 2 ; Goschzik, T 6 ; Doz, F 7 ; Rutkowski, S 8 ; Lannering, B 9 ; Pietsch, T 6 ; Bailey, S 2 ; Williamson, D 2 ; Clifford, S C 2 

 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Northumbria University, Newcastle upon Tyne, UK 
 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK 
 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Queen’s University,, Belfast, UK 
 Agena, Hamburg, Germany 
 NewGene, Newcastle upon Tyne, UK 
 Department of Neuropathology, University of Bonn Medical Center, Bonn, Germany 
 Institut Curie and University Paris Descartes, Paris, France 
 University Medical Center Hamburg-Eppendorf, Hamburg, Germany 
 Department of Pediatrics, University of Gothenburg and the Queen Silvia Children’s Hospital, Gothenburg, Sweden 
Pages
1-8
Publication year
2017
Publication date
Oct 2017
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2121477642
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.